Pharma Focus Asia

Neuvivo Begins Manufacturing of NP001 for Treatment of ALS

Thursday, May 12, 2022

Neuvivo, a biopharmaceutical company dedicated to delivering an effective, safe ALS treatment to patients, today announced that it has initiated cGMP manufacturing of NP001 for the treatment of ALS (Lou Gehrig's Disease).  The company expects to have product available by the end of the year for clinical use.

NP001 has received FDA's Fast Track and Orphan Drug designation.  It has been shown to be effective and safe in clinical trials.  Published data show a 38% slowing of disease progression as measured by ALSFRS-R score and importantly, a 51% slowing of the decline in lung function compared to placebo.  There have been no serious adverse events reported in clinical trials.

Neuvivo is partnering with Patheon, ThermoFisher's industry leading API contract development and manufacturing organization (CDMO).  Manufacturing will be performed at Patheon's facility in Florence, South Carolina, a site acquired from Roche Holdings.

"We spent the past months evaluating manufacturing options and are pleased to announce our drug development partnership with ThermoFisher to produce NP001 for clinical use," said Ari Azhir, PhD, Founder and CEO, Neuvivo.  "We anticipate having quantities of drug available by the end of the year and possibly sooner.  All at Neuvivo recognize the nature of this terrible disease and the need to make more effective treatments available as soon as possible."

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024